AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) ), a number of preclinical
trials has been conducted Methods: 2D and 3D structures
is caused by structural and functional changes in amygdala, prefrontal cortex and striatum. The
trialsBikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Holz, Frank G.,
Panda-Jonas, Songhomitra,
Gilemzianova, Leisan I.,
Khakimov, Dinar A.,
Jonas, Jost B. (2023) or systemic adverse effects. During the study period, axial length remained unchanged.
Trial registration